Coherus BioSciences, Inc.
CHRS
$0.7818
-$0.0349-4.27%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 111.98% | 99.79% | 88.89% | 78.15% | 18.46% |
| Total Depreciation and Amortization | 39.17% | 40.44% | 20.19% | 12.06% | 2.49% |
| Total Amortization of Deferred Charges | 72.79% | 200.88% | 37.23% | -11.99% | -62.57% |
| Total Other Non-Cash Items | -222.04% | -258.91% | -197.78% | -176.47% | -21.81% |
| Change in Net Operating Assets | 251.78% | 107.90% | 167.71% | 45.64% | 53.54% |
| Cash from Operations | 88.31% | 76.33% | 77.82% | 40.22% | 27.47% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -98.19% | 239.72% | 214.70% | 220.28% | 183.52% |
| Cash from Investing | 59.24% | 1,400.36% | 542.42% | 390.11% | 186.69% |
| Total Debt Issued | -- | -- | -24.99% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -96.40% | -95.87% | -78.53% | 338.25% | 692.20% |
| Repurchase of Common Stock | 30.97% | 17.49% | 16.23% | 59.89% | 4.19% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3,604.64% | 3,098.25% | 2,712.61% | 39.50% | 15.80% |
| Cash from Financing | -368.64% | -346.40% | -254.56% | 11.17% | 28.12% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -41.80% | 108.35% | 142.62% | 178.71% | 111.13% |
